Inadvertent diclofenac rechallenge from generic and non-generic prescribing, leading to liver transplantation for fulminant liver failure
- 1 January 2001
- journal article
- case report
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 13 (1), 71-73
- https://doi.org/10.1097/00042737-200101000-00014
Abstract
This case report describes fulminant hepatic failure in a 53-year-old female caused by inadvertent rechallenging with diclofenac, treated by orthotopic liver transplantation. The case also illustrates the hazards of using both generic and non-generic drug prescribing, with drugs that are known to be toxic. The literature on non-steroidal anti-inflammatory drugs and hepatoxicity is reviewed.Keywords
This publication has 12 references indexed in Scilit:
- Meloxicam: Selective COX-2 inhibition in clinical practiceSeminars in Arthritis and Rheumatism, 1997
- Idiosyncratic Liver Toxicity of Nonsteroidal Antiinflammatory Drugs: Molecular Mechanisms and PathologyCritical Reviews in Toxicology, 1995
- Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factorsArchives of Internal Medicine, 1994
- Diclofenac induced hepatitisDigestive Diseases and Sciences, 1993
- Diclofenac associated hepatitisJournal of Hepatology, 1990
- Changing the class of NSAID in cases of hepatotoxicity.Annals Of The Rheumatic Diseases, 1988
- Cross hepatotoxicity between non-steroidal anti-inflammatory drugs.BMJ, 1987
- Diclofenac hepatitis.BMJ, 1982
- Report on a Long-Term Tolerability Study of Up to Two Years with Diclofenac Sodium (Voltaren)Scandinavian Journal of Rheumatology, 1977